Logo for Navidea Biopharmaceuticals Inc

Navidea Biopharmaceuticals Investor Relations Material

Latest events

Logo for Navidea Biopharmaceuticals Inc

EGM 2024

Navidea Biopharmaceuticals
Logo for Navidea Biopharmaceuticals

EGM 2024

8 Jul, 2024
Logo for Navidea Biopharmaceuticals

Q3 2023

14 Nov, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Navidea Biopharmaceuticals Inc

Access all reports
Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on developing precision immunodiagnostic agents and immunotherapeutics. Its primary technology platform, Manocept, is designed to target the CD206 receptor found on activated macrophages, which plays a key role in diagnosing and treating diseases such as cancer, autoimmune conditions, and inflammatory diseases. The company operates through two main segments: Diagnostic Substances, which include imaging agents, and Therapeutic Development Programs, aimed at therapeutic applications of its platform. Navidea is headquartered in Dublin, Ohio, and its shares are traded on the OTC Markets.